334 related articles for article (PubMed ID: 24616506)
1. Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7.
He WA; Calore F; Londhe P; Canella A; Guttridge DC; Croce CM
Proc Natl Acad Sci U S A; 2014 Mar; 111(12):4525-9. PubMed ID: 24616506
[TBL] [Abstract][Full Text] [Related]
2. The TLR7/8/9 Antagonist IMO-8503 Inhibits Cancer-Induced Cachexia.
Calore F; Londhe P; Fadda P; Nigita G; Casadei L; Marceca GP; Fassan M; Lovat F; Gasparini P; Rizzotto L; Zanesi N; Jackson D; Mehta S; Nana-Sinkam P; Sampath D; Pollock RE; Guttridge DC; Croce CM
Cancer Res; 2018 Dec; 78(23):6680-6690. PubMed ID: 30209066
[TBL] [Abstract][Full Text] [Related]
3. The Pathway to Cancer Cachexia: MicroRNA-Regulated Networks in Muscle Wasting Based on Integrative Meta-Analysis.
Freire PP; Fernandez GJ; Cury SS; de Moraes D; Oliveira JS; de Oliveira G; Dal-Pai-Silva M; Dos Reis PP; Carvalho RF
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013615
[TBL] [Abstract][Full Text] [Related]
4. Expression of CCAAT/Enhancer Binding Protein Beta in Muscle Satellite Cells Inhibits Myogenesis in Cancer Cachexia.
Marchildon F; Lamarche É; Lala-Tabbert N; St-Louis C; Wiper-Bergeron N
PLoS One; 2015; 10(12):e0145583. PubMed ID: 26709824
[TBL] [Abstract][Full Text] [Related]
5. Cancer Cachexia and MicroRNAs.
Camargo RG; Quintas Teixeira Ribeiro H; Geraldo MV; Matos-Neto E; Neves RX; Carnevali LC; Donatto FF; Alcântara PS; Ottoch JP; Seelaender M
Mediators Inflamm; 2015; 2015():367561. PubMed ID: 26504359
[TBL] [Abstract][Full Text] [Related]
6. Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation.
Quan-Jun Y; Yan H; Yong-Long H; Li-Li W; Jie L; Jin-Lu H; Jin L; Peng-Guo C; Run G; Cheng G
Mol Cancer Ther; 2017 Feb; 16(2):334-343. PubMed ID: 27599525
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA in Cancer and Cachexia--A Mini-Review.
Acunzo M; Croce CM
J Infect Dis; 2015 Jul; 212 Suppl 1(Suppl 1):S74-7. PubMed ID: 26116737
[TBL] [Abstract][Full Text] [Related]
8. Skeletal muscle is enriched in hematopoietic stem cells and not inflammatory cells in cachectic mice.
Berardi E; Aulino P; Murfuni I; Toschi A; Padula F; Scicchitano BM; Coletti D; Adamo S
Neurol Res; 2008 Mar; 30(2):160-9. PubMed ID: 18397608
[TBL] [Abstract][Full Text] [Related]
9. Identification of microRNAs in skeletal muscle associated with lung cancer cachexia.
van de Worp WRPH; Schols AMWJ; Dingemans AC; Op den Kamp CMH; Degens JHRJ; Kelders MCJM; Coort S; Woodruff HC; Kratassiouk G; Harel-Bellan A; Theys J; van Helvoort A; Langen RCJ
J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):452-463. PubMed ID: 31828982
[TBL] [Abstract][Full Text] [Related]
10. Impaired Muscle Regeneration in Cancer-Associated Cachexia.
Arneson PC; Doles JD
Trends Cancer; 2019 Oct; 5(10):579-582. PubMed ID: 31706505
[TBL] [Abstract][Full Text] [Related]
11. Dual Inhibition of MEK and PI3K/Akt Rescues Cancer Cachexia through both Tumor-Extrinsic and -Intrinsic Activities.
Talbert EE; Yang J; Mace TA; Farren MR; Farris AB; Young GS; Elnaggar O; Che Z; Timmers CD; Rajasekera P; Maskarinec JM; Bloomston M; Bekaii-Saab T; Guttridge DC; Lesinski GB
Mol Cancer Ther; 2017 Feb; 16(2):344-356. PubMed ID: 27811010
[TBL] [Abstract][Full Text] [Related]
12. Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia.
Martinelli GB; Olivari D; Re Cecconi AD; Talamini L; Ottoboni L; Lecker SH; Stretch C; Baracos VE; Bathe OF; Resovi A; Giavazzi R; Cervo L; Piccirillo R
Oncogene; 2016 Dec; 35(48):6212-6222. PubMed ID: 27212031
[TBL] [Abstract][Full Text] [Related]
13. MC38 Tumors Induce Musculoskeletal Defects in Colorectal Cancer.
Huot JR; Pin F; Essex AL; Bonetto A
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540821
[TBL] [Abstract][Full Text] [Related]
14. Cancer cachexia-induced muscle atrophy: evidence for alterations in microRNAs important for muscle size.
Lee DE; Brown JL; Rosa-Caldwell ME; Blackwell TA; Perry RA; Brown LA; Khatri B; Seo D; Bottje WG; Washington TA; Wiggs MP; Kong BW; Greene NP
Physiol Genomics; 2017 May; 49(5):253-260. PubMed ID: 28341621
[TBL] [Abstract][Full Text] [Related]
15. Mouse models of cancer-induced cachexia: Hind limb muscle mass and evoked force as readouts.
Jourdain M; Melly S; Summermatter S; Hatakeyama S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2415-2420. PubMed ID: 29969629
[TBL] [Abstract][Full Text] [Related]
16. NF-κB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia.
He WA; Berardi E; Cardillo VM; Acharyya S; Aulino P; Thomas-Ahner J; Wang J; Bloomston M; Muscarella P; Nau P; Shah N; Butchbach ME; Ladner K; Adamo S; Rudnicki MA; Keller C; Coletti D; Montanaro F; Guttridge DC
J Clin Invest; 2013 Nov; 123(11):4821-35. PubMed ID: 24084740
[TBL] [Abstract][Full Text] [Related]
17. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.
Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E
J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129
[TBL] [Abstract][Full Text] [Related]
18. Myostatin is a novel tumoral factor that induces cancer cachexia.
Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M
Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320
[TBL] [Abstract][Full Text] [Related]
19. Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.
Talbert EE; Guttridge DC
Semin Cell Dev Biol; 2016 Jun; 54():82-91. PubMed ID: 26385617
[TBL] [Abstract][Full Text] [Related]
20. Endoplasmic Reticulum Stress, Calcium Dysregulation and Altered Protein Translation: Intersection of Processes That Contribute to Cancer Cachexia Induced Skeletal Muscle Wasting.
Isaac ST; Tan TC; Polly P
Curr Drug Targets; 2016; 17(10):1140-6. PubMed ID: 25882219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
